GL1X · GenesisL1 explorer

Research workbench

Structure-based design of trifarotene (CD5789), a potent and selective rar gamma agonist for the treatment of acne

Analyse Structure-based design of trifarotene (CD5789), a potent and selective rar… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FX0
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor gamma
UniProt
P13631
Ligands
E9T
Pockets
3 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor gammaprotein23868% helix, 4% strandP13631

Ligands and binding sites

  • E9T · 6-[3-(1-adamantyl)-4-oxidanyl-phenyl]naphthalene-2-carboxylic acid · ligand · chains A
  • PG4 · Tetraethylene glycol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12430.820.9438E9T
2990.480.8120empty
3860.450.8015empty

Compared structures

  • 6FX0 · Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist… · the same entry in another collection · chain A against A, TM-score 1.00
  • P13631 · AlphaFold monomer V2.0 prediction for retinoic acid receptor gamma (P13631) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.